
CIK 0001496443
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Newcomer MarkDirector, CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $767K 50.0K sh | Oct 14, 2026 traded Oct 9, 2026 | |
Ngo Michael CChief Innovation Officer |
Open-market sale |
| SELL |
| $900K 70.1K sh |
| Sep 10, 2026 traded Sep 8, 2026 |
| 26 | Ngo Michael CChief Innovation Officer | Open-market sale | SELL | $1.02M 79.9K sh | Sep 10, 2026 traded Sep 9, 2026 |
| 39 | Cunningham Bradley KramerChief Technology Officer | Open-market sale | SELL | $73K 10.0K sh | Sep 4, 2026 traded May 29, 2026 |
| 30 | Turner Matthew BakerPRES., PATIENT AFFORDABILITY | Tax withholding | F | $341K 50.7K sh | Sep 4, 2026 traded May 22, 2026 |
| 27 | Cunningham Bradley KramerChief Technology Officer | Tax withholding | F | $73K 12.4K sh | Sep 4, 2026 traded May 18, 2026 |
| 32 | Cunningham Bradley KramerChief Technology Officer | Open-market sale | SELL | $23K 3,000 sh | Sep 4, 2026 traded Jun 1, 2026 |
| 22 | Cunningham Bradley KramerChief Technology Officer | Tax withholding | F | $201K 22.4K sh | Sep 4, 2026 traded Jul 31, 2026 |
| 36 | Turner Matthew BakerPRES., PATIENT AFFORDABILITY | Grant or award | A | — 233.3K sh | Sep 4, 2026 traded Nov 13, 2025 |
| 23 | Cunningham Bradley KramerChief Technology Officer | Tax withholding | F | $95K 11.6K sh | Sep 4, 2026 traded Jun 30, 2026 |
| 39 | Turner Matthew BakerPRES., PATIENT AFFORDABILITY | Open-market sale | SELL | $63K 15.1K sh | Sep 4, 2026 traded Feb 3, 2026 |
| 31 | Baker Jeffery BradfordChief Financial Officer | Open-market sale | SELL | $442K 35.0K sh | Aug 14, 2026 traded Aug 12, 2026 |
| 15 | Herman Joan MDirector, EVP, Operations | Open-market sale · 10b5-1 plan | SELL | $801K 100.0K sh | Jun 30, 2026 traded Jun 26, 2026 |